NCT07754305

Brief Summary

The research investigating the effects of Diaphragm-Pelvic Floor Synergy (DPFS) training targets primary dysmenorrhea in university-aged females. This randomized controlled trial evaluates how restoring the functional "piston" relationship between the diaphragm and pelvic floor can alleviate menstrual pain and enhance quality of life. By implementing an eight-week progressive exercise protocol, the study compares DPFS training against standard symptomatic care like TENS and heat therapy. Using the WALIDD scale and WHOQOL-BREF, the research aims to establish a non-pharmacological, evidence-based physiotherapy intervention that reduces medication reliance and academic absenteeism in South Asian clinical settings.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Jul 2026Dec 2026

Study Start

First participant enrolled

July 28, 2026

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

August 5, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 10, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

August 10, 2026

Status Verified

August 1, 2026

Enrollment Period

3 months

First QC Date

August 5, 2026

Last Update Submit

August 7, 2026

Conditions

Keywords

Diaphragm-Pelvic Floor SynergyQuality of LifeYoung FemalesPrimary Dysmenorrhea

Outcome Measures

Primary Outcomes (1)

  • Working Ability, Location, Intensity, Days of pain, and Dysmenorrhea (WALIDD) Scale

    The WALIDD scale is a validated multi-dimensional tool used to assess the severity of primary dysmenorrhea. It evaluates five specific areas: work interference, anatomical location of pain, pain intensity, duration of symptoms, and the clinical grade of dysmenorrhea. Scores range from 0 to 12, where 1-4 indicates mild, 5-7 moderate, and 8-12 severe pain.

    Baseline (Pre-intervention), 8 weeks (Immediate post-intervention), and 3 months (Follow-up).

Secondary Outcomes (1)

  • : World Health Organization Quality of Life-BREF (WHOQOL-BREF)

    Baseline (Pre-intervention), 8 weeks (Immediate post-intervention), and 3 months (Follow-up).

Study Arms (2)

Diaphragm-Pelvic Floor Synergy (DPFS) Training

EXPERIMENTAL

Participants in this group undergo an active neuromuscular re-education protocol. The intervention focuses on restoring the "piston-like" coordination between the thoracic diaphragm and the pelvic floor muscles. Over an 8-week period, participants perform supervised exercises three times per week that synchronize breathing with pelvic floor activation. The training is progressive, advancing through four postural stages (supine, sitting, quadruped, and standing) to challenge the core's ability to regulate intra-abdominal pressure and alleviate symptoms of primary dysmenorrhea.

Behavioral: Diaphragm-Pelvic Floor Synergy (DPFS) Training

Standard Symptomatic Care

ACTIVE COMPARATOR

This group serves as the clinical control, receiving conventional physiotherapy typically used for menstrual pain relief. During the first three days of the menstrual cycle, participants receive passive modalities, including High-Frequency Transcutaneous Electrical Nerve Stimulation (TENS) and moist heat therapy. On non-menstrual days, the group performs supervised Progressive Muscle Relaxation (PMR) three times per week. This design ensures that the control group remains as active as the experimental group while receiving standard-of-care treatments for symptom management.

Device: Transcutaneous Electrical Nerve Stimulation (TENS)

Interventions

This intervention is a supervised 8-week program consisting of 3 sessions per week. It focuses on the functional coordination of the thoracic diaphragm and pelvic floor muscles to regulate intra-abdominal pressure. The protocol involves a "piston" technique where participants perform a 4-second slow inhalation (allowing the pelvic floor to relax and descend) followed by a 6-second pursed-lip exhalation (actively contracting and elevating the pelvic floor). The training is progressive, advancing every two weeks through four postural levels: supine, sitting, quadruped, and standing.

Diaphragm-Pelvic Floor Synergy (DPFS) Training

This arm receives established clinical treatments for menstrual pain. During the first three days of the menstrual cycle, participants receive 30 minutes of High-Frequency Transcutaneous Electrical Nerve Stimulation (TENS) at 100 Hz and 20 minutes of moist heat therapy. On non-menstrual days, they participate in supervised Progressive Muscle Relaxation (PMR) sessions three times per week to manage general muscle tension and stress.

Standard Symptomatic Care

Eligibility Criteria

Age18 Years - 24 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • University going girls aged 18-24 years.
  • Normal weight (BMI 18.5-24.9 kg/m²) based on measured height and weight.
  • Primary dysmenorrhea: recurrent menstrual pain without pelvic pathology, present for ≥6 months, with pain intensity ≥4/10 on VAS.
  • Regular menstrual cycles (21-35 days).
  • From socioeconomically disadvantaged backgrounds (e.g., low parental education, low household income, government/public school enrolment - specify in protocol).
  • Currently enrolled in school/college.
  • Informed consent/assent obtained (with parental consent if \<18 years).
  • Willing to participate in intervention and data collection.

You may not qualify if:

  • diagnosed pelvic pathologies (e.g., endometriosis, fibroids, pelvic inflammatory disease).
  • Irregular menstrual cycles (\<21 days or \>35 days).
  • Current or recent use of hormonal contraceptives or hormonal therapy (within last 3 months).
  • History of pelvic/abdominal surgery.
  • Pregnancy or recent childbirth (within 6 months).
  • Any diagnosed musculoskeletal, neurological, or medical condition contraindicating exercise or acupressure.
  • Current participation in another clinical trial or structured exercise/physiotherapy program for dysmenorrhea.
  • Unwillingness to provide consent/assent or comply with study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prime Institute of Health Sciences, Islamabad

Islamabad, Punjab Province, 44000, Pakistan

Location

MeSH Terms

Conditions

Dysmenorrhea

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • Summra Andleeb, MSOMPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Summra Andleeb, MSOMPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2026

First Posted

August 10, 2026

Study Start

July 28, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 10, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations